1. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. Issue 10323 (29th January 2022) Authors: Attard, Gerhardt; Murphy, Laura; Clarke, Noel W; Cross, William; Jones, Robert J; Parker, Christopher C; Gillessen, Silke; Cook, Adrian; Brawley, Chris; Amos, Claire L; Atako, Nafisah; Pugh, Cheryl; Buckner, Michelle; Chowdhury, Simon; Malik, Zafar; Russell, J Martin; Gilson, Clare; Rush, Hannah;... Journal: Lancet Issue: Volume 399:Issue 10323(2022) Page Start: 447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476). Issue 3 (16th May 2022) Authors: James, Nicholas D.; Clarke, Noel W.; Cook, Adrian; Ali, Adnan; Hoyle, Alex P.; Attard, Gerhardt; Brawley, Christopher D.; Chowdhury, Simon; Cross, William R.; Dearnaley, David P.; de Bono, Johann S.; Diaz‐Montana, Carlos; Gilbert, Duncan; Gillessen, Silke; Gilson, Clare; Jones, Rob J.; Langley, R... Journal: International journal of cancer Issue: Volume 151:Issue 3(2022) Page Start: 422 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial. Issue 4 (25th July 2022) Authors: James, Nicholas D; Ingleby, Fiona C; Clarke, Noel W; Amos, Claire L; Attard, Gerhardt; Brawley, Christopher D; Chowdhury, Simon; Cross, William; Dearnaley, David P; Gilbert, Duncan C; Gillessen, Silke; Jones, Robert J; Langley, Ruth E; Macnair, Archie; Malik, Zafar I; Mason, Malcolm D; Matheson, ... Journal: JNCI cancer spectrum Issue: Volume 6:Issue 4(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hemi‐ablative low‐dose‐rate prostate brachytherapy for unilateral localised prostate cancer. (23rd December 2019) Authors: Langley, Stephen; Uribe, Jennifer; Uribe‐Lewis, Santiago; Franklin, Adrian; Perna, Carla; Horton, Alex; Cunningham, Melanie; Higgins, Donna; Deering, Claire; Khaksar, Sara; Laing, Robert Journal: BJU international Issue: Volume 125:Number 3(2020) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long‐term oncological outcomes and toxicity in 597 men aged ≤60 years at time of low‐dose‐rate brachytherapy for localised prostate cancer. (2nd August 2017) Authors: Langley, Stephen E. M.; Soares, Ricardo; Uribe, Jennifer; Uribe‐Lewis, Santiago; Money‐Kyrle, Julian; Perna, Carla; Khaksar, Sara; Laing, Robert Journal: BJU international Issue: Volume 121:Number 1(2018) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long‐term survival after low‐dose‐rate brachytherapy for prostate cancer: the Royal Surrey experience. (22nd September 2021) Authors: Uribe‐Lewis, Santiago; Uribe, Jennifer; Bourke, Vincent; Deering, Claire; Higgins, Donna; Mehta, Sheel; Mikropoulos, Christos; Otter, Sophie; Perna, Carla; Khaksar, Sara; Laing, Robert; Langley, Stephen Journal: BJU international Issue: Volume 129:Number 6(2022) Page Start: 723 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Low‐dose‐rate brachytherapy for the treatment of localised prostate cancer in men with a high risk of disease relapse. (8th May 2018) Authors: Laing, Robert; Uribe, Jennifer; Uribe‐Lewis, Santiago; Money‐Kyrle, Julian; Perna, Carla; Chintzoglou, Stylianos; Khaksar, Sara; Langley, Stephen E.M. Journal: BJU international Issue: Volume 122:Number 4(2018) Page Start: 610 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Low‐Dose‐Rate Prostate Brachytherapy (LDR‐PB) adopts postsurgical PSA value for definition of cure. Issue 1 (19th October 2020) Authors: Uribe, Jennifer; Uribe‐Lewis, Santiago; Khaksar, Sara; Perna, Carla; Mikropoulos, Christos; Otter, Sophie; Laing, Robert; Langley, Stephen Journal: BJUI Compass Issue: Volume 2:Issue 1(2021) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Low‐Dose‐Rate Prostate Brachytherapy (LDR‐PB) adopts postsurgical PSA value for definition of cure. Issue 1 (19th October 2020) Authors: Uribe, Jennifer; Uribe‐Lewis, Santiago; Khaksar, Sara; Perna, Carla; Mikropoulos, Christos; Otter, Sophie; Laing, Robert; Langley, Stephen Journal: BJUI Compass Issue: Volume 2:Issue 1(2021) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial. Issue 8 (10th March 2022) Authors: Rush, Hannah L.; Murphy, Laura; Morgans, Alicia K.; Clarke, Noel W.; Cook, Adrian D.; Attard, Gerhardt; Macnair, Archie; Dearnaley, David P.; Parker, Christopher C.; Russell, J. Martin; Gillessen, Silke; Matheson, David; Millman, Robin; Brawley, Christopher D.; Pugh, Cheryl; Tanguay, Jacob S.; Jo... Journal: Journal of clinical oncology Issue: Volume 40:Issue 8(2022) Page Start: 825 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗